{
  "id": 16297413,
  "title": "Martine Rothblatt, United Therapeutics CEO, sells $5.5M in stock",
  "url": "https://urgent.news/2026/10/24/martine-rothblatt-united-therapeutics-ceo-sells-5-5m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-24T07:16:16.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/martine-rothblatt-united-therapeutics-ceo-sells-55m-in-stock-93CH-4970676"
  },
  "original_language": "en",
  "account": "Martine A. Rothblatt, the Chairperson and CEO of United Therapeutics Corp, exercised stock options and later sold shares, amounting to around $5.54 million. This occurred on October 22, 2026, under a pre-set 10b5-1 trading plan since November 7, 2025. On that date, she bought 9,500 shares at $117.76 each, totaling $1,118,720. The company's stock was traded near its 52-week high of $609.35, up over 40% in the past year. Rothblatt's shares were held indirectly through a family trust. Post the sale, she held 324,603 shares indirectly via this trust. United Therapeutics recently reported a revenue miss in Q2, leading to a price target reduction by BofA Securities. However, legal victories, including a settlement with Liquidia Technologies for $380.7 million, and patent rulings have led to price targets being raised by firms like Jefferies and Cantor Fitzgerald, setting them at $728. BTIG upgraded the company to Buy with a price target of $728, citing a significant legal win. However, Goldman Sachs initiated coverage with a Sell rating and a price target of $321, highlighting issues with the company’s trading metrics and declining base business.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}